Anal-rectal cytology: The other pap test

Published

Journal Article

Anal cancer screening programs are gaining momentum within the United States and Europe. The goal of such programs is to detect and eradicate human papillomavirus (HPV) related intraepithelial lesions of the anal canal before progression to invasive squamous cell carcinoma occurs. Programs are designed to screen the anal-rectal transformation zone of a highly selected group of at-risk patients using exfoliative cytology techniques, comparable to the cervical Pap test. Patients with abnormal cytology results should be referred for anoscopy, during which the anal-rectal mucosa will be carefully visually inspected by a qualified physician. Abnormal areas are biopsied for definitive histological diagnosis, and treatment should be offered as appropriate. A comprehensive anal cancer screening program should offer screening, anoscopy when indicated, and treatment for affected patients as clinically appropriate.

Full Text

Duke Authors

Cited Authors

  • Bean, SM; Chhieng, DC

Published Date

  • March 1, 2010

Published In

Volume / Issue

  • 41 / 3

Start / End Page

  • 168 - 171

International Standard Serial Number (ISSN)

  • 0007-5027

Digital Object Identifier (DOI)

  • 10.1309/LMHYS464MYWZOXFW

Citation Source

  • Scopus